The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Zarrabian Saiid since year 2005.
The trader's CIK number is 1495521.
At the time of this reporting, Zarrabian Saiid is the Interim CEO of Delmar Pharmaceuticals, Inc. .
(stock ticker symbol DMPI).
See this page for all insider trading activities at Delmar Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-14||DMPI||Delmar Pharmaceuticals, Inc.||Buy||60,900||.83||50,547|
|2015-05-14||LJPC||La Jolla Pharmaceutical Co||Buy||307||19.50||5,986|
|2014-07-31||LJPC||La Jolla Pharmaceutical Co||Buy||381||9.53||3,630|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zarrabian Saiid (Interim CEO of Delmar Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.